HomeVKTX • NASDAQ
add
Viking Therapeutics Inc
Previous close
$34.63
Day range
$34.15 - $37.19
Year range
$18.92 - $70.40
Market cap
4.17B USD
Avg Volume
4.82M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 98.56M | 169.62% |
Net income | -90.79M | -264.02% |
Net profit margin | — | — |
Earnings per share | -0.81 | -268.18% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 714.57M | -23.20% |
Total assets | 739.42M | -21.16% |
Total liabilities | 26.38M | -0.21% |
Total equity | 713.03M | — |
Shares outstanding | 113.04M | — |
Price to book | 5.46 | — |
Return on assets | -31.44% | — |
Return on capital | -32.63% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -90.79M | -264.02% |
Cash from operations | -94.00M | -328.03% |
Cash from investing | 160.02M | 517.83% |
Cash from financing | 480.00K | -80.97% |
Net change in cash | 66.50M | 933.83% |
Free cash flow | -64.87M | -303.63% |
About
CEO
Founded
2012
Website
Employees
51
